Middle East Tech Today
SEE OTHER BRANDS

The best science and technology news from the Middle East

Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on May 15, 2025

Surfshark expands Dedicated IP with new locations

Surfshark expands Dedicated IP with new locations

Surfshark, a cybersecurity company, expands its Dedicated IP service to seven new locations, now offering unique, static IP (Internet Protocol) addresses in 20 locations worldwide. This expansion provides users with reliable access to IP-sensitive services …

US Rare Cancer Market FDA Approved Rare Cancer Drug Clinical Trials Insight

US Rare Cancer Market FDA Approved Rare Cancer Drug Clinical Trials Insight

Delhi, May 15, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights: US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030 …

Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates

- Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 - - Phase 2 MoonStone trial in Relapsing Multiple Sclerosis enrollment concluding; topline results expected early in the fourth quarter …

Kraig Biocraft Laboratories Receives Business License to Begin Operations in Cambodia

Kraig Biocraft Laboratories Receives Business License to Begin Operations in Cambodia

ANN ARBOR, Mich., May 15, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, announces today that it has officially received its business license to begin …

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization 

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization 

Salt Lake City, UT , May 15, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT), an advanced ceramics company pioneering medical and antipathogenic applications of silicon nitride (Si₃N₄), today provided a comprehensive update on its …

Microchip Brings Hardware Quantum Resistance to Embedded Controllers

Microchip Brings Hardware Quantum Resistance to Embedded Controllers

CHANDLER, Ariz., May 15, 2025 (GLOBE NEWSWIRE) -- Driven by advancements in cryptographic research and the need for stronger security measures, the National Security Agency (NSA) introduced the Commercial National Security Algorithm Suite 2.0 (CNSA 2.0) to …

Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights

Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights

PEMGARDA™ (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales force PEMGARDA revenue re-acceleration observed in Q2 2025 to date Invivyd continues to …

Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results

Updated clinical data from Emi-Le Phase 1 dose escalation and backfill cohorts presented today at ESMO Breast Cancer 2025 ORR increased to 31% across tumor types among evaluable patients with B7-H4 high tumors receiving intermediate doses Encouraging …

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

LEXINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced the first peer-reviewed publication of data demonstrating …

Annual Report and Notice of Meeting

Annual Report and Notice of Meeting

Reykjavík, May 15, 2025 (GLOBE NEWSWIRE) -- (“Amaroq Minerals” or the “Company”) Annual Report and Notice of Meeting TORONTO, ONTARIO – May 15, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a substantial …

Axovia Therapeutics Unveils New Preclinical Data for AXV-201, for Treatment of Genetic Obesity Caused by MC4R Mutations, at ASGCT

Axovia Therapeutics Unveils New Preclinical Data for AXV-201, for Treatment of Genetic Obesity Caused by MC4R Mutations, at ASGCT

LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and obesity, announced that today it will unveil new preclinical proof-of-concept data for novelly …

CRN Recognizes Nine Climb Channel Solutions Employees on the 2025 ‘Women of the Channel’ List and Names Climb CMO Kim Stevens as one of the 2025 Women of the Channel Power 100

CRN Recognizes Nine Climb Channel Solutions Employees on the 2025 ‘Women of the Channel’ List and Names Climb CMO Kim Stevens as one of the 2025 Women of the Channel Power 100

EATONTOWN, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), announced Monday, May 13, 2025 that CRN®, a brand of …

Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

SAN FRANCISCO, May 15, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …

Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer

Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer

Two independent Phase 2 trials demonstrate extended progression-free survival in patients without TP53 mutations or without liver metastases Results presented at 2025 ESMO Breast Cancer Annual Congress BOSTON, May 15, 2025 (GLOBE NEWSWIRE) -- Carrick …

Verde Announces Q1 2025 Results

Verde Announces Q1 2025 Results

(All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in Q1 2025: C$1.00 = R$3.93) SINGAPORE, May 15, 2025 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: “NPK”) ("Verde” or the “Company”) announces its financial results for the …

Sumanth Channabasappa Brings Industry-Defining Technology Expertise to Vetty

Sumanth Channabasappa Brings Industry-Defining Technology Expertise to Vetty

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Vetty, the one-stop shop hiring acceleration platform, announced that Sumanth Channabasappa has joined the company effective May 5, 2025. An entrepreneur, growth strategist, product and technology leader and …

Salary.com Brings Compensation Technology Insights to WorldatWork Total Rewards ‘25

Salary.com Brings Compensation Technology Insights to WorldatWork Total Rewards ‘25

WALTHAM, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- WHO:     Salary.com, a leading provider of compensation market data and software         WHAT:     Will exhibit and present compensation insights during WorldatWork Total Rewards ‘25.         WHEN:     The …

Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts

Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts

       – Two subtype specific cohorts with ~15 patients each added to the ongoing RESET-Myositis™ trial – – RMAT designation granted for rese-cel in myositis, which is a disabling, multi-system autoimmune disease affecting approximately 80,000 U.S. …

Aya Gold & Silver Publishes 2024 Sustainability Report

Aya Gold & Silver Publishes 2024 Sustainability Report

MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce that is has published its 2024 Sustainability Report for the year ended December 31, 2024 (the “Report”). The …

SYLOGIST Reports First Quarter 2025 Results

SYLOGIST Reports First Quarter 2025 Results

Q1 2025 Highlights1               Revenue (in $ millions)   SaaS Subscription Recurring Total Reported Y/Y growth Reported Y/Y growth Reported Y/Y growth $7.8 15% $10.9 6% $16.3 3%   SaaS ARR up 15% Y/Y to $31.4 million; ARR up 6% Y/Y to $44.3 million; …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service